The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
- PMID: 16321986
- DOI: 10.1093/hmg/ddi439
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
Abstract
Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) have been recently identified in families with autosomal dominant late-onset Parkinson disease (PD). The LRRK2 protein consists of multiple domains and belongs to the Roco family, a novel group of the Ras/GTPase superfamily. Besides the GTPase (Roc) domain, it contains a predicted kinase domain, with homology to MAP kinase kinase kinases. Using cell fractionation and immunofluorescence microscopy, we show that LRRK2 is localized in the cytoplasm and is associated with cellular membrane structures. The purified LRRK2 protein demonstrates autokinase activity. The disease-associated I2020T mutant shows a significant increase in autophosphorylation of approximately 40% in comparison to wild-type protein in vitro. This suggests that the pathology of PD caused by the I2020T mutation is associated with an increase rather than a loss in LRRK2 kinase activity.
Similar articles
-
Dominant-negative effects of LRRK2 heterodimers: a possible mechanism of neurodegeneration in Parkinson's disease caused by LRRK2 I2020T mutation.Biochem Biophys Res Commun. 2013 Jan 11;430(2):560-6. doi: 10.1016/j.bbrc.2012.11.113. Epub 2012 Dec 7. Biochem Biophys Res Commun. 2013. PMID: 23220480
-
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.J Neurochem. 2009 May;109(4):959-68. doi: 10.1111/j.1471-4159.2009.06024.x. Epub 2009 Mar 3. J Neurochem. 2009. PMID: 19302196
-
Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.J Proteome Res. 2010 Apr 5;9(4):1738-45. doi: 10.1021/pr9008578. J Proteome Res. 2010. PMID: 20108944
-
Contribution of GTPase activity to LRRK2-associated Parkinson disease.Small GTPases. 2013 Jul-Sep;4(3):164-70. doi: 10.4161/sgtp.25130. Epub 2013 Jun 10. Small GTPases. 2013. PMID: 24025585 Free PMC article. Review.
-
Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.Biochem Soc Trans. 2012 Oct;40(5):1058-62. doi: 10.1042/BST20120054. Biochem Soc Trans. 2012. PMID: 22988865 Review.
Cited by
-
Parkinson's disease: leucine-rich repeat kinase 2 and autophagy, intimate enemies.Parkinsons Dis. 2012;2012:151039. doi: 10.1155/2012/151039. Epub 2012 Aug 30. Parkinsons Dis. 2012. PMID: 22970411 Free PMC article.
-
Eiger-induced cell death relies on Rac1-dependent endocytosis.Cell Death Dis. 2016 Apr 7;7(4):e2181. doi: 10.1038/cddis.2016.80. Cell Death Dis. 2016. PMID: 27054336 Free PMC article.
-
Structural model of the dimeric Parkinson's protein LRRK2 reveals a compact architecture involving distant interdomain contacts.Proc Natl Acad Sci U S A. 2016 Jul 26;113(30):E4357-66. doi: 10.1073/pnas.1523708113. Epub 2016 Jun 29. Proc Natl Acad Sci U S A. 2016. PMID: 27357661 Free PMC article.
-
Inhibition of Parkinson's disease-related LRRK2 by type I and type II kinase inhibitors: Activity and structures.Sci Adv. 2023 Dec;9(48):eadk6191. doi: 10.1126/sciadv.adk6191. Epub 2023 Dec 1. Sci Adv. 2023. PMID: 38039358 Free PMC article.
-
The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.Hum Genet. 2007 Feb;120(6):857-63. doi: 10.1007/s00439-006-0268-0. Epub 2006 Sep 30. Hum Genet. 2007. PMID: 17019612
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases